Search results

The purpose of this study is to explore the contextual determinants of HIV risk among people who inject drugs (PWID) in public settings in Nigeria.

In-depth, individual interviews were conducted with 29 street-based PWID recruited through snowball sampling in Uyo, Nigeria. Interviews were tape-recorded, transcribed, coded and analysed hematically.

Homelessness and withdrawal pains encouraged consumption of drugs in public spaces (e.g. bunks, public parks). Conversely, the benefits of participation in street drug-use scenes, including reciprocity norms that guarantee free drugs during withdrawal and protection during overdose, fostered a preference for public injecting. Although participants recognized the need to inject with sterile syringes, scarcity of syringes compelled them to improvise with old syringes or share syringes, increasing risk for HIV transmission. HIV risk was exacerbated by unlawful and discriminatory policing practices, which deterred possession of syringes and encouraged risky behaviours such as rushing injection and sharing of equipment.

Contextual factors are key determinants of HIV risk for street-based PWID. Implementation of needle and syringe programmes as well as reforming legal frameworks and policing practices to support harm reduction are needed responses.

This is one of very few qualitative studies that explore risk factors for HIV transmission among PWID in West Africa. The focus on scarcity of sterile syringes and HIV risk is unique and has important policy implications.

Abuse and reuse of syringes will let nursing professionals suffer serious risk of cross-infection of diseases. The purpose of this paper is to propose a flexible and extensible innovative design approach of single-use safety syringe. Besides, the evaluation procedure for syringe has also been developed.

By using the innovative design processes, based on the Su-Field model and extension method, this study presents designing of a new single-use safety syringe incorporating features and discarding problems.

The solution of design problem indicated that the substance “fingers grip cap” should be replaced. The advantages and disadvantages of proposed new designs of safety syringe as well as the perceived differences on the use of the safety syringes can be found out by using Focus Group Interview method.

This research focussed on the function innovation without considering the psychology effect, such as shape aesthetics and users’ emotion.

The single-use safety syringe design and corresponding examples are adopted to explain the design processes and confirm the feasibility of the proposed approach.

This paper proposes a flexible and extensible innovative design approach of single-use safety syringe which is seldom studied. Importance and emergency of safety syringe design cannot be overemphasized.

The authors aimed to examine the incarceration experiences of injecting drug users in accessing harm reduction, and HIV‐related services inside prisons in India.

The authors conducted three focus groups with a purposive sample of 23 formerly incarcerated male IDUs and four key informant interviews with a former police official, a drug dealer and service providers. Data were analyzed using a constant comparative method.

Participants reported availability of alcohol and injectable or oral drugs such as heroin, dextropropoxyphene, and marijuana inside prisons. Inmates obtained drugs and clean syringes (one syringe bought for 2.5‐4 USD) through prison staff, and collected used syringes and needles from the dustbins in prison sickrooms. Needles and syringes were reused and shared. Prisons did not have needle and syringe programmes, detoxification, overdose management or opioid substitution treatment. Drug‐using prison inmates faced several challenges in accessing antiretroviral treatment and HIV testing.

The authors' findings emphasize the need to protect the health of injection drug‐using inmates by introducing harm reduction programmes and removing barriers to HIV testing and antiretroviral treatment.

This study illustrates, for the first time, the contexts behind high risk injecting drug use behaviours among prison inmates in India. It also highlights the lack of availability of harm reduction services such as needle and syringe programmes, drug detoxification and opioid substitution treatment inside prisons. Further, it demonstrates the difficulties faced by HIV‐positive prison inmates in getting timely and uninterrupted antiretroviral treatment.

This article examines the issue of prison needle‐exchange programmes (PNEP) based upon the international experience and evidence in six countries. A review of existing literature was undertaken together with original research comprising site visits to prison needle‐exchange programmes in four countries operating such initiatives in October 2002. During the course of the research, prison needle exchange programmes were initiated in two other countries, Kyrgyzstan and Belarus. Site visits were not possible in respect of these two countries, and data was gathered via conversations with staff and funding organisations involved and by the examination of documentary evidence. The paper presents an overview of the PNEP initiated and a commentry on the outcomes. Based upon the evidence emerging from the investigation, the paper concludes that while prison syringe‐exchange programmes have been implemented in diverse environments and under differing circumstances, the results of the programmes have been remarkably consistent. Improved prisoner health and reduction of needle sharing have been achieved. Fears of violence, increased drug consumption, and other negative consequences have not materialised. Based on the evidence and experience, it can be concluded unequivocally that prison needle‐exchange programmes effectively address the health‐related harms associated with needle sharing in prisons and do not undermine institutional safety or security.

The use of the glass syringe as an instrument in school chemistry for the measuring of gases was first developed by Dr Schmit in Hamburg as long ago as 1931. Its use has spread very slowly through Europe and the author himself only came across the syringe during a tour of Europe in 1963, sponsored by the Nuffield Foundation. The 100ml glass syringe consists essentially of a precision ground barrel and a plunger which is so well made that it is gas‐tight at atmospheric pressure even without the use of a lubricant. With a light grease, such as Vaseline, the syringe is gas‐tight even under comparatively heavy pressures.

This study aims to report the development of an open-source syringe extrusion head for shear-thinning materials. The target is to adapt open-source 3D printers to be helpful in research lines that use gels, hydrogels, pastes, inks, and bio-inks.

This hardware was designed to be compatible with a Graber i3-based 3D printer; nevertheless, it can be easily adapted to other open-source 3D printers.

The extrusion head successfully deposits the material during the 3D printing process. It was validated fabricating geometries that include scaffold structures, which are a possible application of bioprinting for tissue engineering. As reported, the extruded filaments allowed the porous samples' structuration.

This system expands the applications of open-source 3D printers used at the laboratory scale. It enables low-cost access to research areas such as tissue engineering and biofabrication, energy storage devices and food 3D printing.

The open-source hardware here reported is of simple fabrication, assembly and installation. It uses a Cardan coupling and a three guides system to transfer the stepper motor motion. This approach allows continuous movement transfer to the syringe piston, producing an adequate deposition or retraction. Thus, the effect of misalignments is avoided, considering that these latter can cause skipping steps in the motor, directly affecting the deposition.

The rates of HIV infection among prisoners in most countries are significantly higher than in the general population. HCV seroprevalence rates are even higher. While most prisoners living with HIV or AIDS and/or HCV contract their infection(s) outside the institutions before imprisonment, there is evidence that the risk of being infected in prison, in particular through sharing of contaminated injecting equipment and through unprotected sex, is great. Outbreaks of HIV infection have been documented in a number of countries. Since the early 1990s, various countries have introduced HIV and, to a lesser extent, HCV prevention programmes in prisons. Part 2 of the select annotated bibliography on HIV/AIDS and HCV in prisons contains selected “essential” articles and reports that provide information about (1) prevalence of HIV, HCV, and risk behaviours in prisons; (2) transmission of HIV and HCV in prisons; and (3) measures aimed at preventing HIV and HCV infection in prisons: education, voluntary testing and counselling, provision of condoms, prevention of rape, sexual violence and coercion and bleach and needle and syringe programmes. Each section also contains a brief review of the evidence, based on recent work undertaken by WHO.

Efforts to establish harm reduction interventions in Italy have persisted since the mid-1990s. Despite this, no sanctioned SIF has ever been implemented. The purpose of this paper is to provide information about a 10 year unsanctioned drug user-run SIF experience in Italy called Stanzetta.

The aim of the paper is to assess how Stanzetta met its objectives. Analysis was conducted compiling narrative accounts from the staff working in the NSP, which is adjacent to the Stanzetta, and conducting a simple frequency analysis of the available statistical data.

The Stanzetta unsanctioned SIF has been running for ten years and continues to be vulnerable due to its legal status. Being open 24 h/days has maximised its accessibility, but at the same time, it has encouraged a misuse of the Stanzetta. Although not trained, drug users became self-empowered to run the Stanzetta and to keep it clean, but the hygiene-health aspect is seen as one of the greatest challenges by the NSP professional staff. Over 10 years, not a single overdose death has been recorded. Drug use in the park has shifted from more visible places to the Stanzetta. As a result, the abandoned syringes have diminished in number and those disposed of correctly have increased. Moreover, no complaints from citizens or law enforcement were ever made. The neighbourhood acceptance seems to be the main goal of the peer-run unsanctioned SIF.

The paper is based on a narrative account from the point of view of the professional staff involved, and results are specific to the context in which the study was conducted. Because of the chosen approach, the research results lack scientific generalisability. A relevant limitation is that no peer was involved in this study. Despite this, the research contributes to the information based on peer-run SIFs and makes a case for the de-medicalisation of SIFs in Europe.

This paper gives visibility to a long-lasting drug user-run SIF experience that was not made public mostly for an unclear legislative background about SIF in Italy.

Efforts to establish harm reduction interventions in Italy have persisted since the mid-1990s and were undertaken primarily in response to epidemics of HIV infection and overdose (DPA, 2017). Despite this, no sanctioned SIF has ever been implemented. Primarily, this study wants to underline the urgency for an SIF pilot in Italy, and secondly the need to consider de-medicalising these services through direct support for peer-based models.

The Stanzetta unsanctioned SIF in Italy that has been running for ten years. Despite this, the venue continues to be vulnerable due to its legal status. For this reason, these results were never made public before. The experience showed a good working synergy between NSP professionals and the SIF peers. This model can be considered as a “light” de-medicalisation form to be explored and eventually to be implemented as a pilot SIF in Italy.

In Kyrgyzstan the prevalence of injecting drug behaviour is among the highest found throughout the world. Health promotion training, improved health care and needle/syringe exchange (NSE) programmes have been shown to decrease risk behaviour among injecting drug users. In Kyrgyzstan, an intervention study with training of prison staff and prisoners was performed in one prison. Before and after the training, a random selection of the prisoners answered a questionnaire about drug use, risk behaviour and health care. The survey was carried out in both the intervention prison and in a reference prison. The number of drug users, the use of drugs and risk behaviour were improved significantly within half a year and, especially, the injection and use of drugs decreased in the intervention group. The study clearly shows that increased focus, improved healthcare and training of prisoners and staff on drug use and harm reduction can reduce both use of drugs and risk behaviour.

In June 2001‐July 2002 the New South Wales Corrections Health Service was providing a range of health services for approximately 8,000 full‐time inmates. This figure is steadily increasing. A prison environment is a dynamic one and 17,000 inmates have come through our gates in the past year. A prison environment is efficient for transmission of infections such as HIV, Hepatitis C and Tuberculosis, to name but a few.The New South Wales Inmate Health Survey showed that about 80% of inmates have injected drugs at least once in their life, 40% report that they have injected drugs within a week prior to entry into gaol and 20% will continue to inject whilst in gaol. These figures appear repeatedly in both national and international figures. Some 80% of males and 70% of females have a history of illicit drug use.A comprehensive search of electronic databases, journal publications, conference presentations and discussions with experts involved with development of research and policy documents in regard to harm minimisation in a correctional setting was collected for this presentation. This paper attempts to look at a number of intervention strategies both nationally and internationally for prisoners to reduce their risks of acquiring a bloodborne virus. Methadone programs, bleach, condoms and prison‐based syringe exchange programmes are examined. How does Australia rate amongst other nations in reducing the risk?